About ResoTher Pharma
We create novel medicines that benefit patients in need
ResoTher Pharma is a clinical stage biotechnology company located in Copenhagen, Denmark. We are on a mission to deliver new and effective treatment options for patients suffering from cardiovascular disease.
Our peptide-based drugs address the pathological role of inflammation by acting as resolution therapy, terminating the inflammatory response and inducing regeneration in the affected tissue.
Recent clinical discoveries pinpoint inflammation as an important determinant of prognosis in cardiovascular disease, an opportunity for therapeutic intervention that is not addressed by currently available treatments.
We focus on acute, critical-care, cardiovascular interventions with a big unmet medical need. We believe that our novel, pro-resolving therapies have potential to provide additional therapeutic benefit for these patients.